6.85 (0.76%) Natco Pharma has submitted a copy of the presentation made to analysts /Investors on Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2016.
The above information is a part of company’s filings submitted to BSE.